A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

This publication has 23 references indexed in Scilit:

• Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2003
• Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
  Circulation, 2003
• Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene Therapy
  Journal of Clinical Oncology, 2003
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Published by Massachusetts Medical Society ,2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice
  Molecular and Cellular Endocrinology, 1998
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
  New England Journal of Medicine, 1997
• Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer
  Annals of Surgery, 1994
• Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
  JNCI Journal of the National Cancer Institute, 1990